Showing results (751-760 of 788) with videos related to
Sort By:
Pageof 79
In Silico Pharmacology|December 27, 2023
Potentiality of bioactive compounds as inhibitor of M protein and F protein function of human respiratory syncytial virusDebanjan Mitra, Manish Paul, Hrudayanath Thatoi, et al.In Silico Pharmacology|June 15, 2026
IGF-1 receptor ATP-competitive inhibitors for the treatment of Ewing sarcoma: a comprehensive virtual screening analysis for a dataset of molecules showing a wide range of chemical structuresValentina Guaitoli, Yoanna María Alvarez-Ginarte, Luis Alberto Montero-Cabrera, et al.In Silico Pharmacology|June 23, 2026
Computational investigation of Bisabolol as a MexB inhibitor against Meropenem-resistant Pseudomonas aeruginosaPraveena Nanjan, B Vanitha, A P CardiliyaIn Silico Pharmacology|June 23, 2026
In silico and in vitro antibacterial investigation of Origanum majorana L. leaves extract against gram-positive and gram-negative bacteriaRajan Rolta, Deeksha Salaria, Megha Soni, et al.In Silico Pharmacology|June 23, 2026
In-silico evaluation of Azadirachta indica (neem) against DprE1 of Mycobacterium tuberculosis with functional characterisationTolulope Sharon Rumide, Abidemi Esther Ojo, Regina Oghenevwede Golagha, et al.In Silico Pharmacology|June 23, 2026
Targeting A549 cells: the synthesis and multi-omic characterization of a high-affinity hydrazone derivativePoorasamy Punithavalli, Ezhumalai Sivaprakash, Antony Baburajan Therasa AlphonsaIn Silico Pharmacology|June 23, 2026
Rational design and synthesis of theophylline-based hybrids as bacterial DHFR inhibitors: integrating molecular modelling and ADME prediction with biological validationJyoti, Garima, Nitish Kumar, et al.In Silico Pharmacology|July 1, 2026
Integrated synthesis and computational assessment of sulfanilamide-triazolo-oxadiazole triads as effective ALP and amylase inhibitorsBisma Iqbal, Aamer Saeed, Mian Bilal Haider, et al.In Silico Pharmacology|July 2, 2026
Integrated in vivo and in silico evaluation of Coccinia grandis (L.) Voigt root constituents reveals dual targeting of 5-HT3A and D2 receptors in emesisShubham N Kanawade, Ravindra B Laware, Rahul K Kunkulol, et al.In Silico Pharmacology|June 26, 2026
Proteomics-based pathway analysis and anticancer activity of OSF2, a bioactive fraction from Oecophylla smaragdina, supported by in silico dockingSuman Jangir, Varalakshmi Kilingar NadumanePageof 79